RIL
TBPH

Rothschild Investment LLC’s Theravance Biopharma TBPH Stock Holding History

Rothschild Investment LLC’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18K Buy
187
+52
+39% +$861 ﹤0.01% 2530
2026
Q1 		$2.19K Sell
135
-1
-0.7% -$18 ﹤0.01% 2515
2025
Q4 		$2.54K Buy
136
+1
+0.7% +$17 ﹤0.01% 2243
2025
Q3 		$1.97K Hold
135
– – ﹤0.01% 2243
2025
Q2 		$1.49K Buy
135
+25
+23% +$243 ﹤0.01% 2251
2025
Q1 		$982 Sell
110
-15
-12% -$140 ﹤0.01% 2351
2024
Q4 		$1.18K Buy
+125
New +$1.14K ﹤0.01% 2113

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rothschild Investment LLC's TBPH Position: Q2 2026 in Review

Rothschild Investment LLC increased its Theravance Biopharma (TBPH) stake by 39% in Q2 2026, buying an estimated $861 and bringing the position to 187 shares worth $3.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

Rothschild Investment LLC first reported a position in TBPH in Q4 2024 and has held it in 7 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Rothschild Investment LLC held 187 shares of Theravance Biopharma worth $3.18K as of Q2 2026.
  • Rothschild Investment LLC bought 52 Theravance Biopharma shares in Q2 2026, an estimated $861.
  • Theravance Biopharma made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2530 holding.
  • Rothschild Investment LLC first reported a position in Theravance Biopharma in Q4 2024 and has held it in 7 quarters since.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.